Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25545| Title: | Mycosis fungoides and Sézary syndrome: Australian clinical practice statement. | Austin Authors: | Bhabha, Friyana K;McCormack, Christopher;Wells, Jillian;Campbell, Belinda A;Newland, Kate;Lade, Stephen;Buelens, Odette;Joske, David;Shortt, Jake;Mapp, Sally;Radeski, Dejan;Hertzberg, Mark;Khot, Amit;Van Der Weyden, Carrie;Khoo, Christine;Hawkes, Eliza A ;Prince, H Miles | Affiliation: | Nurse Practitioner, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing & Health Sciences, Monash University, Clayton, Victoria, Australia Department of Haematology, Monash Health, Clayton, Victoria, Australia Department of Dermatology, Flinders Medical Centre, Bedford Park, South Australia, Australia Department of Dermatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia Department of Dermatology, Westmead Hospital and The University of Sydney, Sydney, New South Wales, Australia Department of Dermatology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Haematology Department, Princess Alexandra Hospital, Brisbane, Australia Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Olivia Newton-John Cancer Research Institute Eastern Health, Box Hill, Victoria, Australia University of Melbourne, Melbourne, Victoria, Australia Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Department of Haematology, Prince of Wales Hospital, Randwick, Australia |
Issue Date: | Feb-2021 | Date: | 2020-12-26 | Publication information: | The Australasian Journal of Dermatology 2021; 62(1): e8-e18 | Abstract: | Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas with distinct clinical presentations, histopathologic features, treatment approaches and outcomes. The cutaneous T-cell lymphomas, which include mycosis fungoides and Sézary syndrome, account for the majority of the cutaneous lymphomas. This Clinical Practice Statement is reflective of the current clinical practice in Australia. An expanded form of the Clinical Practice Statement (and updates), along with helpful patient resources and access to support groups, can be found at the following (http://www.australasianlymphomaalliance.org.au). | URI: | https://ahro.austin.org.au/austinjspui/handle/1/25545 | DOI: | 10.1111/ajd.13467 | ORCID: | 0000-0002-6067-4694 | Journal: | The Australasian Journal of Dermatology | PubMed URL: | 33368169 | Type: | Journal Article | Subjects: | Sézary syndrome clinical practices statement cutaneous T-cell lymphoma management mycosis fungoides |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.